Literature DB >> 4739865

Superior vena cava syndrome. Complication of permanent transvenous endocardial cardiac pacing.

M Wertheimer, R K Hughes, C H Castle.   

Abstract

Entities:  

Mesh：

Year:  1973        PMID： 4739865     DOI： 10.1001/jama.224.8.1172

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

1.  Superior vena cava stenosis at site of intersection of two pacing electrodes.

Authors:  M Pauletti; R Pingitore; C Contini
Journal:  Br Heart J       Date:  1979-10

2.  Superior vena caval stenosis: a complication of transvenous endocardial pacing.

Authors:  D M Matthews; J C Forfar
Journal:  Thorax       Date:  1979-06       Impact factor: 9.139

3.  Benign superior vena cava syndrome caused by transvenous cardiac pacemaker.

Authors:  J V Cholankeril; R R Joshi; S Ketyer
Journal:  Cardiovasc Intervent Radiol       Date:  1982       Impact factor: 2.740

4.  Large right atrial thrombosis. Rare complication during permanent transvenous endocardial pacing.

Authors:  G L Nicolosi; P A Charmet; D Zanuttini
Journal:  Br Heart J       Date:  1980-02

Review 5.  Venous Obstruction in Cardiac Rhythm Device Therapy.

Authors:  Joseph Donnelly; James Gabriels; Andrew Galmer; Jonathan Willner; Stuart Beldner; Laurence M Epstein; Apoor Patel
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-07-11

6.  Be aware of wires in the veins: a case of superior vena cava syndrome in a patient with permanent pacemaker.

Authors:  Agegnehu T Gebreyes; Hom Nath Pant; Donna M Williams; Sapna P Kuehl
Journal:  J Community Hosp Intern Med Perspect       Date:  2012-10-15

Review 7.  Surgical management of superior vena cava syndrome following pacemaker lead infection: a case report and review of the literature.

Authors:  John Kokotsakis; Umar A R Chaudhry; Dimitris Tassopoulos; Leanne Harling; Hutan Ashrafian; Michail Vernandos; Meletis Kanakis; Thanos Athanasiou
Journal:  J Cardiothorac Surg       Date:  2014-06-19       Impact factor: 1.637
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.